SlideShare a Scribd company logo
1 of 14
Download to read offline
Zaragoza, 27-28 April 2017
Patient Involvement in HTA:
the Spanish experience
Pedro Serrano Aguilar y Ana Toledo Chávarri
Servicio de Evaluación y Planificación del Servicio Canario de Salud
PUBLIC HEALTH CONFERENCE
10th anniversary of the Spanish Network of Health Technology Assessment (HTA) Agencies:
Insights for collaborative networking
Towards Patient and public engagement in HTA
Introduction
This presentations will cover the following themes:
- What are the main challenges that Spanish HTA bodies need to involve patients in
their regular activity?
- Strategies and activities in Spanish agencies to incorporate patients in HTA.
- Which are the key factors in moving beyond good-willed theory to real experience of
patient engagement in HTA?
- What are the previous experiences do we have on patient involvement (PI)?
- What is an expert patient? What do you expect from her? Programs and services to
support effective patient participation?
The Spanish HTA Network: RedETS
Commitment with Patient Involvement
•The Spanish Ministry of Health and the RedETS recognise the need and value of
active participation of patients to improve decisions in relation to HTA
•Patients have unique knowledges, experiences and perspectives that can contribute
in an essencial manner to HTA.
• Making explicit, understanding and applying this knowledge can improve the answer
given to patients' needs;
• Improve democratization, transparency, responsability and sustainability in decision
making.
Main identified challenges
• Increasingly open RedETS to patient participation in its
different activities.
• Involve patients in all HTA reports.
• Develop procedures and methodology to involve patients
allowing them to make valuable contribution
• Inform and train patients, HTA developers and other agents
for PI
Facilitators of Pacient Involvement
• Previous PI experiences in Evidence Based
Products
– Clinical Practice Guidelines:
• Breastfeeding and Diabetes (Osteba)
• Depression in children (Avalia-t)
• Inherited Retinal Dystrofia and Lupus (SESCS)
• PI methodology (IACS)
– SDM Tools (AQUAS, ISCIII, SESCS...)
– Evidence Based products for patients
• PyDesalud.com (SESCS)
• Sarcoidosis (Avalia-T) or IRD guides for patients
– HTA (SESCS)
• Blood glucose monitoring device
• Neonatal screening
– And some failures... (Prostate Cancer Genetic test, SESCS)
Reviewing our experience
• Interviews with HTA Units directors and
expert patients
• HTA perspective
– Overall satisfaction
– Some worries:
• What patients?: representativity and diversity
• Lobby
• Expert patients perspective
– Increasing satisfaction
– We must be prepared for specific contributions from
patients and how to use them
Patient Involvement Sgtrategy
2016: PI Methodological Handbook (DRAFT on REVIEW)
- Methodology:
- SR
- In-depth Interviews,
- Delphi,
- and consensus in the HTA Netwok Council
- Results:
- Methodological framework and tools adapted to the work of the Spanish HTA
Network (expected contributions, who, how).
- Proposal: Patient Involvement Strategy: Including short, medium and long term
actions was discussed in the RedETS governing body in March 2017
Short Term: Patient Involment in 2017
The Patient Involvement Strategy for 2017:
1. Public Declaration
2. Establish procedures for patient intivation, selection and participation to
RedETS activities
3. Pilot experiences: Most RedETS HTA agencies will increasingly involve patients
in HTA reports, starting along 2017, to test the procedures and learn from
experience. Patients will involve in:
1) protocol development (helping to define objectives and scope of the report);
2) reviewing the preliminary version of the HTA report.
3) Contributing to the patient version of the summaries
Firts Actions in 2017
4. Training materials for patientes. (IACS, Madrid, Avalia-T and SESCS).
5. Declaration of interest document adapted for patient participation.
6. Promoting sinergies with other spaces for patient participation establised by
the Spanish Ministry of Health as the Network of Health Schools for Citizenship.
Mid term PI actions (2018-2019)
1. Extend the scope of patient participation: reviewing literature and other resources to
introduce patient related issues in HTA reports
2. Training for HTA technicians to improve capacity on patient involvement and on the
incorporation of patient contribution to HTA reports
3. Dissemination activities targeting patients, carers and users and their associations
4. Active disemination of the public alegations calls to increase participation of patients
associations.
5. PI Evaluation: conduct a qualitative evaluation and create a checklist to facilitate PI and
transparency
Long term PI actions
1. Extend patient participation to all HTA reports
2. Modify methodologies and procedures in relation to the results of the evaluation
3. Establish mechanisms to incorporate and document patient contributions and
document them in a transparent manner
4. Conduct primary studies to introduce patient perspective in HTA when necessary
5. Ensure representativity and diversity in patient involvement
6. Consider patient participation in RedETS structure
7. Adapt current selection and priorization tools to allow patient involvement
• RedETS commitment with IP
• Increasing capacity for effective patient participation
• and a long road to drive on...
Conclusions
anatoledochavarri@sescs.es
Thanks!

More Related Content

What's hot

Good practices in patient involvement in HTA
Good practices in patient involvement in HTAGood practices in patient involvement in HTA
Good practices in patient involvement in HTAEUPATI
 
Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
 
Consumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTAConsumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTACochrane.Collaboration
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsEUPATI
 
Webinar: Guidance on Industry-led R&D
Webinar: Guidance on Industry-led R&DWebinar: Guidance on Industry-led R&D
Webinar: Guidance on Industry-led R&DHibernia College
 
Health Technology Assessment
Health Technology AssessmentHealth Technology Assessment
Health Technology AssessmentEUPATI
 
Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.EUPATI
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisionsEUPATI
 
Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...
Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...
Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...Hibernia College
 
Webinar on EUPATI Guidance on Patient Involvement in Regulatory Processes
Webinar on EUPATI Guidance on Patient Involvement in Regulatory ProcessesWebinar on EUPATI Guidance on Patient Involvement in Regulatory Processes
Webinar on EUPATI Guidance on Patient Involvement in Regulatory ProcessesHibernia College
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldjangeissler
 
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...jangeissler
 
The patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the NetherlandsThe patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the NetherlandsEUPATI
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI
 

What's hot (20)

Jornadas #PatientInHTA · Yolanda Triñanes
Jornadas #PatientInHTA · Yolanda TriñanesJornadas #PatientInHTA · Yolanda Triñanes
Jornadas #PatientInHTA · Yolanda Triñanes
 
Jornadas #PatientInHTA · Iñaki Imaz
Jornadas #PatientInHTA · Iñaki ImazJornadas #PatientInHTA · Iñaki Imaz
Jornadas #PatientInHTA · Iñaki Imaz
 
Jornadas #PatientInHTA ·Ruth Ubago
Jornadas #PatientInHTA ·Ruth UbagoJornadas #PatientInHTA ·Ruth Ubago
Jornadas #PatientInHTA ·Ruth Ubago
 
Good practices in patient involvement in HTA
Good practices in patient involvement in HTAGood practices in patient involvement in HTA
Good practices in patient involvement in HTA
 
Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?
 
Jornadas #PatientInHTA · Gaizka Benguria
Jornadas #PatientInHTA · Gaizka BenguriaJornadas #PatientInHTA · Gaizka Benguria
Jornadas #PatientInHTA · Gaizka Benguria
 
Consumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTAConsumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTA
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentations
 
Webinar: Guidance on Industry-led R&D
Webinar: Guidance on Industry-led R&DWebinar: Guidance on Industry-led R&D
Webinar: Guidance on Industry-led R&D
 
Health Technology Assessment
Health Technology AssessmentHealth Technology Assessment
Health Technology Assessment
 
Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisions
 
Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...
Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...
Webinar on EUPATI Guidance for Patient Involvement in Ethical Review of Clini...
 
Webinar on EUPATI Guidance on Patient Involvement in Regulatory Processes
Webinar on EUPATI Guidance on Patient Involvement in Regulatory ProcessesWebinar on EUPATI Guidance on Patient Involvement in Regulatory Processes
Webinar on EUPATI Guidance on Patient Involvement in Regulatory Processes
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Observatory of Innovation in healthcare management in Catalonia (OIGS)
Observatory of Innovation in healthcare management in Catalonia (OIGS)Observatory of Innovation in healthcare management in Catalonia (OIGS)
Observatory of Innovation in healthcare management in Catalonia (OIGS)
 
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
 
The patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the NetherlandsThe patients' contribution to ethics committees in the Netherlands
The patients' contribution to ethics committees in the Netherlands
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
 
Engaging with EMA methodology
Engaging with EMA methodology Engaging with EMA methodology
Engaging with EMA methodology
 

Similar to Jornadas #PatientInHTA · Ana Toledo

PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016ipposi
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017ipposi
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSIipposi
 
Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.HTAi Bilbao 2012
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europeipposi
 
Derick mitchell
Derick mitchellDerick mitchell
Derick mitchellHIQAHIS
 
Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017ipposi
 
100_HOPE_Hospitals_2020_complete_September_2015
100_HOPE_Hospitals_2020_complete_September_2015100_HOPE_Hospitals_2020_complete_September_2015
100_HOPE_Hospitals_2020_complete_September_2015Justin Beardsmore
 
HCS_Patient_and_Public_Involvement_Report
HCS_Patient_and_Public_Involvement_ReportHCS_Patient_and_Public_Involvement_Report
HCS_Patient_and_Public_Involvement_Reportfavori12
 
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...GuíaSalud
 
Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020Elena Petelos
 
Right Care Overview and National Roll Out
Right Care Overview and National Roll OutRight Care Overview and National Roll Out
Right Care Overview and National Roll Outian.mckinnell
 
An Overview of the Right Care philosopy and approach
An Overview of the Right Care philosopy and approachAn Overview of the Right Care philosopy and approach
An Overview of the Right Care philosopy and approachrightcare
 
JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene EU_CHRODIS
 
eHealth Ecosystem - Dr Derick Mitchell - October 2017
eHealth Ecosystem - Dr Derick Mitchell - October 2017eHealth Ecosystem - Dr Derick Mitchell - October 2017
eHealth Ecosystem - Dr Derick Mitchell - October 2017ipposi
 

Similar to Jornadas #PatientInHTA · Ana Toledo (20)

PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
 
Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.
 
1 engaging with ema methodology and support
1 engaging with ema methodology and support1 engaging with ema methodology and support
1 engaging with ema methodology and support
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe
 
Derick mitchell
Derick mitchellDerick mitchell
Derick mitchell
 
Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017
 
100_HOPE_Hospitals_2020_complete_September_2015
100_HOPE_Hospitals_2020_complete_September_2015100_HOPE_Hospitals_2020_complete_September_2015
100_HOPE_Hospitals_2020_complete_September_2015
 
HCS_Patient_and_Public_Involvement_Report
HCS_Patient_and_Public_Involvement_ReportHCS_Patient_and_Public_Involvement_Report
HCS_Patient_and_Public_Involvement_Report
 
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
 
Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020
 
Essencial Project in Catalonia. Avoiding low-value clinical practices
Essencial Project in Catalonia. Avoiding low-value clinical practicesEssencial Project in Catalonia. Avoiding low-value clinical practices
Essencial Project in Catalonia. Avoiding low-value clinical practices
 
Right Care Overview and National Roll Out
Right Care Overview and National Roll OutRight Care Overview and National Roll Out
Right Care Overview and National Roll Out
 
An Overview of the Right Care philosopy and approach
An Overview of the Right Care philosopy and approachAn Overview of the Right Care philosopy and approach
An Overview of the Right Care philosopy and approach
 
CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?
 
JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene
 
eHealth Ecosystem - Dr Derick Mitchell - October 2017
eHealth Ecosystem - Dr Derick Mitchell - October 2017eHealth Ecosystem - Dr Derick Mitchell - October 2017
eHealth Ecosystem - Dr Derick Mitchell - October 2017
 
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
Dr. Jordi Martínez, ICT Strategy in the Catalan Health Care and Social Care S...
 

More from Instituto Aragonés de Ciencias de la Salud - IACS

More from Instituto Aragonés de Ciencias de la Salud - IACS (18)

Jornadas #PatientInHTA · Gaizka Benguria
Jornadas #PatientInHTA · Gaizka BenguriaJornadas #PatientInHTA · Gaizka Benguria
Jornadas #PatientInHTA · Gaizka Benguria
 
Sesiones Clínicas de Investigación e Innovación 2017. Huesca
Sesiones Clínicas de Investigación e Innovación 2017. HuescaSesiones Clínicas de Investigación e Innovación 2017. Huesca
Sesiones Clínicas de Investigación e Innovación 2017. Huesca
 
Tipos de proyectos que deben ser evaluados por un CEIC
Tipos de proyectos que deben ser evaluados por un CEICTipos de proyectos que deben ser evaluados por un CEIC
Tipos de proyectos que deben ser evaluados por un CEIC
 
Tipos de CEI
Tipos de CEITipos de CEI
Tipos de CEI
 
Marco normativo de los ensayos clínicos. Novedades RD 1090/2015
Marco normativo de los ensayos clínicos. Novedades RD 1090/2015Marco normativo de los ensayos clínicos. Novedades RD 1090/2015
Marco normativo de los ensayos clínicos. Novedades RD 1090/2015
 
Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...
Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...
Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...
 
Comités de ética en la investigación con animales
Comités de ética en la investigación con animalesComités de ética en la investigación con animales
Comités de ética en la investigación con animales
 
Integridad científica
Integridad científicaIntegridad científica
Integridad científica
 
Cómo elaborar una hoja de información para recabar el consentimiento informado
Cómo elaborar una hoja de información para recabar el consentimiento informadoCómo elaborar una hoja de información para recabar el consentimiento informado
Cómo elaborar una hoja de información para recabar el consentimiento informado
 
Qué hace que una investigación sea ética
Qué hace que una investigación sea éticaQué hace que una investigación sea ética
Qué hace que una investigación sea ética
 
Biobancos y colecciones de muestras biologicas
Biobancos y colecciones de muestras biologicasBiobancos y colecciones de muestras biologicas
Biobancos y colecciones de muestras biologicas
 
Aspectos éticos. Novedades RD 1090/2015
Aspectos éticos. Novedades RD 1090/2015Aspectos éticos. Novedades RD 1090/2015
Aspectos éticos. Novedades RD 1090/2015
 
Manejo de datos en investigacion clinica. Aspectos éticos y legales
Manejo de datos en investigacion clinica. Aspectos éticos y legalesManejo de datos en investigacion clinica. Aspectos éticos y legales
Manejo de datos en investigacion clinica. Aspectos éticos y legales
 
Compra Publica de Innovacion: Proyecto Piloto "Descontaminacion barranco de B...
Compra Publica de Innovacion: Proyecto Piloto "Descontaminacion barranco de B...Compra Publica de Innovacion: Proyecto Piloto "Descontaminacion barranco de B...
Compra Publica de Innovacion: Proyecto Piloto "Descontaminacion barranco de B...
 
Compra Pública de Innovacion. Estructura de gobernanza
Compra Pública de Innovacion. Estructura de gobernanzaCompra Pública de Innovacion. Estructura de gobernanza
Compra Pública de Innovacion. Estructura de gobernanza
 
Estrategia de Compra Publica de Innovación en Aragón: Formación
Estrategia de Compra Publica de Innovación en Aragón: FormaciónEstrategia de Compra Publica de Innovación en Aragón: Formación
Estrategia de Compra Publica de Innovación en Aragón: Formación
 
8. Evaluar tecnologías basadas en mHealth. ¿Es posible un marco común de eval...
8. Evaluar tecnologías basadas en mHealth. ¿Es posible un marco común de eval...8. Evaluar tecnologías basadas en mHealth. ¿Es posible un marco común de eval...
8. Evaluar tecnologías basadas en mHealth. ¿Es posible un marco común de eval...
 
7. Análisis coste-efectividad: ¿un umbral para determinar si el coste de una ...
7. Análisis coste-efectividad: ¿un umbral para determinar si el coste de una ...7. Análisis coste-efectividad: ¿un umbral para determinar si el coste de una ...
7. Análisis coste-efectividad: ¿un umbral para determinar si el coste de una ...
 

Recently uploaded

Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxAntiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxdrdeepikaj
 
Leadership Style - Code and Rapid Response Workshop
Leadership Style - Code and Rapid Response WorkshopLeadership Style - Code and Rapid Response Workshop
Leadership Style - Code and Rapid Response WorkshopBrian Locke
 
PSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdf
PSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdfPSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdf
PSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdfkeerti Gour (PT) Shakya
 
The Pfizer testimony by Melissa Mac Atee
The Pfizer testimony by Melissa Mac AteeThe Pfizer testimony by Melissa Mac Atee
The Pfizer testimony by Melissa Mac AteePascalGuyot6
 
Session-1-MBFHI-A-part-of-the-Global-Strategy.ppt
Session-1-MBFHI-A-part-of-the-Global-Strategy.pptSession-1-MBFHI-A-part-of-the-Global-Strategy.ppt
Session-1-MBFHI-A-part-of-the-Global-Strategy.pptMedidas Medical Center INC
 
Session-5-Birthing-Practices-Breastfeeding (1).ppt
Session-5-Birthing-Practices-Breastfeeding (1).pptSession-5-Birthing-Practices-Breastfeeding (1).ppt
Session-5-Birthing-Practices-Breastfeeding (1).pptMedidas Medical Center INC
 
Personnel and Equipment - Code and Rapid Response Workshop
Personnel and Equipment - Code and Rapid Response WorkshopPersonnel and Equipment - Code and Rapid Response Workshop
Personnel and Equipment - Code and Rapid Response WorkshopBrian Locke
 
Homeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdf
Homeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdfHomeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdf
Homeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdfDharma Homoeopathy
 
Lactation Mraining Management Session-2-Comm-Building-Conf.ppt
Lactation Mraining Management  Session-2-Comm-Building-Conf.pptLactation Mraining Management  Session-2-Comm-Building-Conf.ppt
Lactation Mraining Management Session-2-Comm-Building-Conf.pptMedidas Medical Center INC
 
The Power of Technology and Collaboration in Research - Rheumatology Research...
The Power of Technology and Collaboration in Research - Rheumatology Research...The Power of Technology and Collaboration in Research - Rheumatology Research...
The Power of Technology and Collaboration in Research - Rheumatology Research...Paul Sufka
 
Presentation on Cleft Lip and Cleft Palate
Presentation on Cleft Lip and Cleft PalatePresentation on Cleft Lip and Cleft Palate
Presentation on Cleft Lip and Cleft PalateRahulRoyChowdhury13
 
Session-3-Promoting-Breastfeeding-During-Pregnancy.ppt
Session-3-Promoting-Breastfeeding-During-Pregnancy.pptSession-3-Promoting-Breastfeeding-During-Pregnancy.ppt
Session-3-Promoting-Breastfeeding-During-Pregnancy.pptMedidas Medical Center INC
 
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaDr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaGaurav Gangwani
 
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptxINTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptxAnushriSrivastav
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdfDr. Afreen Nasir
 
Best Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For DietBest Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For DietGunaPerumal1
 
Session-17-KANGAROO-MOTHER-CARE_final-blue.pptx
Session-17-KANGAROO-MOTHER-CARE_final-blue.pptxSession-17-KANGAROO-MOTHER-CARE_final-blue.pptx
Session-17-KANGAROO-MOTHER-CARE_final-blue.pptxMedidas Medical Center INC
 
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...Dr. Afreen Nasir
 
Technology transfer documentation and strategies
Technology transfer documentation and strategiesTechnology transfer documentation and strategies
Technology transfer documentation and strategiesNidhi Joshi
 
An overview of Muir Wood Adolescent and Family Services teen treatment programs.
An overview of Muir Wood Adolescent and Family Services teen treatment programs.An overview of Muir Wood Adolescent and Family Services teen treatment programs.
An overview of Muir Wood Adolescent and Family Services teen treatment programs.pdamico1
 

Recently uploaded (20)

Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxAntiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
 
Leadership Style - Code and Rapid Response Workshop
Leadership Style - Code and Rapid Response WorkshopLeadership Style - Code and Rapid Response Workshop
Leadership Style - Code and Rapid Response Workshop
 
PSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdf
PSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdfPSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdf
PSYCHOLOGICAL ASPECTS OF REHAB. IN PHYSIOTHERAPY..pdf
 
The Pfizer testimony by Melissa Mac Atee
The Pfizer testimony by Melissa Mac AteeThe Pfizer testimony by Melissa Mac Atee
The Pfizer testimony by Melissa Mac Atee
 
Session-1-MBFHI-A-part-of-the-Global-Strategy.ppt
Session-1-MBFHI-A-part-of-the-Global-Strategy.pptSession-1-MBFHI-A-part-of-the-Global-Strategy.ppt
Session-1-MBFHI-A-part-of-the-Global-Strategy.ppt
 
Session-5-Birthing-Practices-Breastfeeding (1).ppt
Session-5-Birthing-Practices-Breastfeeding (1).pptSession-5-Birthing-Practices-Breastfeeding (1).ppt
Session-5-Birthing-Practices-Breastfeeding (1).ppt
 
Personnel and Equipment - Code and Rapid Response Workshop
Personnel and Equipment - Code and Rapid Response WorkshopPersonnel and Equipment - Code and Rapid Response Workshop
Personnel and Equipment - Code and Rapid Response Workshop
 
Homeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdf
Homeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdfHomeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdf
Homeopathy Medicine for Diabetes_ Balancing Blood Sugar .pdf
 
Lactation Mraining Management Session-2-Comm-Building-Conf.ppt
Lactation Mraining Management  Session-2-Comm-Building-Conf.pptLactation Mraining Management  Session-2-Comm-Building-Conf.ppt
Lactation Mraining Management Session-2-Comm-Building-Conf.ppt
 
The Power of Technology and Collaboration in Research - Rheumatology Research...
The Power of Technology and Collaboration in Research - Rheumatology Research...The Power of Technology and Collaboration in Research - Rheumatology Research...
The Power of Technology and Collaboration in Research - Rheumatology Research...
 
Presentation on Cleft Lip and Cleft Palate
Presentation on Cleft Lip and Cleft PalatePresentation on Cleft Lip and Cleft Palate
Presentation on Cleft Lip and Cleft Palate
 
Session-3-Promoting-Breastfeeding-During-Pregnancy.ppt
Session-3-Promoting-Breastfeeding-During-Pregnancy.pptSession-3-Promoting-Breastfeeding-During-Pregnancy.ppt
Session-3-Promoting-Breastfeeding-During-Pregnancy.ppt
 
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaDr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
 
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptxINTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
INTERNATIONAL HEALTH AGENCIES BY ANUSHRI SRIVASTAV.pptx
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
 
Best Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For DietBest Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For Diet
 
Session-17-KANGAROO-MOTHER-CARE_final-blue.pptx
Session-17-KANGAROO-MOTHER-CARE_final-blue.pptxSession-17-KANGAROO-MOTHER-CARE_final-blue.pptx
Session-17-KANGAROO-MOTHER-CARE_final-blue.pptx
 
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
 
Technology transfer documentation and strategies
Technology transfer documentation and strategiesTechnology transfer documentation and strategies
Technology transfer documentation and strategies
 
An overview of Muir Wood Adolescent and Family Services teen treatment programs.
An overview of Muir Wood Adolescent and Family Services teen treatment programs.An overview of Muir Wood Adolescent and Family Services teen treatment programs.
An overview of Muir Wood Adolescent and Family Services teen treatment programs.
 

Jornadas #PatientInHTA · Ana Toledo

  • 1. Zaragoza, 27-28 April 2017 Patient Involvement in HTA: the Spanish experience Pedro Serrano Aguilar y Ana Toledo Chávarri Servicio de Evaluación y Planificación del Servicio Canario de Salud PUBLIC HEALTH CONFERENCE 10th anniversary of the Spanish Network of Health Technology Assessment (HTA) Agencies: Insights for collaborative networking Towards Patient and public engagement in HTA
  • 2. Introduction This presentations will cover the following themes: - What are the main challenges that Spanish HTA bodies need to involve patients in their regular activity? - Strategies and activities in Spanish agencies to incorporate patients in HTA. - Which are the key factors in moving beyond good-willed theory to real experience of patient engagement in HTA? - What are the previous experiences do we have on patient involvement (PI)? - What is an expert patient? What do you expect from her? Programs and services to support effective patient participation?
  • 3. The Spanish HTA Network: RedETS
  • 4. Commitment with Patient Involvement •The Spanish Ministry of Health and the RedETS recognise the need and value of active participation of patients to improve decisions in relation to HTA •Patients have unique knowledges, experiences and perspectives that can contribute in an essencial manner to HTA. • Making explicit, understanding and applying this knowledge can improve the answer given to patients' needs; • Improve democratization, transparency, responsability and sustainability in decision making.
  • 5. Main identified challenges • Increasingly open RedETS to patient participation in its different activities. • Involve patients in all HTA reports. • Develop procedures and methodology to involve patients allowing them to make valuable contribution • Inform and train patients, HTA developers and other agents for PI
  • 6. Facilitators of Pacient Involvement • Previous PI experiences in Evidence Based Products – Clinical Practice Guidelines: • Breastfeeding and Diabetes (Osteba) • Depression in children (Avalia-t) • Inherited Retinal Dystrofia and Lupus (SESCS) • PI methodology (IACS) – SDM Tools (AQUAS, ISCIII, SESCS...) – Evidence Based products for patients • PyDesalud.com (SESCS) • Sarcoidosis (Avalia-T) or IRD guides for patients – HTA (SESCS) • Blood glucose monitoring device • Neonatal screening – And some failures... (Prostate Cancer Genetic test, SESCS)
  • 7. Reviewing our experience • Interviews with HTA Units directors and expert patients • HTA perspective – Overall satisfaction – Some worries: • What patients?: representativity and diversity • Lobby • Expert patients perspective – Increasing satisfaction – We must be prepared for specific contributions from patients and how to use them
  • 8. Patient Involvement Sgtrategy 2016: PI Methodological Handbook (DRAFT on REVIEW) - Methodology: - SR - In-depth Interviews, - Delphi, - and consensus in the HTA Netwok Council - Results: - Methodological framework and tools adapted to the work of the Spanish HTA Network (expected contributions, who, how). - Proposal: Patient Involvement Strategy: Including short, medium and long term actions was discussed in the RedETS governing body in March 2017
  • 9. Short Term: Patient Involment in 2017 The Patient Involvement Strategy for 2017: 1. Public Declaration 2. Establish procedures for patient intivation, selection and participation to RedETS activities 3. Pilot experiences: Most RedETS HTA agencies will increasingly involve patients in HTA reports, starting along 2017, to test the procedures and learn from experience. Patients will involve in: 1) protocol development (helping to define objectives and scope of the report); 2) reviewing the preliminary version of the HTA report. 3) Contributing to the patient version of the summaries
  • 10. Firts Actions in 2017 4. Training materials for patientes. (IACS, Madrid, Avalia-T and SESCS). 5. Declaration of interest document adapted for patient participation. 6. Promoting sinergies with other spaces for patient participation establised by the Spanish Ministry of Health as the Network of Health Schools for Citizenship.
  • 11. Mid term PI actions (2018-2019) 1. Extend the scope of patient participation: reviewing literature and other resources to introduce patient related issues in HTA reports 2. Training for HTA technicians to improve capacity on patient involvement and on the incorporation of patient contribution to HTA reports 3. Dissemination activities targeting patients, carers and users and their associations 4. Active disemination of the public alegations calls to increase participation of patients associations. 5. PI Evaluation: conduct a qualitative evaluation and create a checklist to facilitate PI and transparency
  • 12. Long term PI actions 1. Extend patient participation to all HTA reports 2. Modify methodologies and procedures in relation to the results of the evaluation 3. Establish mechanisms to incorporate and document patient contributions and document them in a transparent manner 4. Conduct primary studies to introduce patient perspective in HTA when necessary 5. Ensure representativity and diversity in patient involvement 6. Consider patient participation in RedETS structure 7. Adapt current selection and priorization tools to allow patient involvement
  • 13. • RedETS commitment with IP • Increasing capacity for effective patient participation • and a long road to drive on... Conclusions